Despite many promoters publicly assaulting me with repeated nonsense on issues they can't provide evidence to support - many of them are actually members of the Keelette Fan Club.
Many promoters have in fact, sent me PMs asking that I explain the German medical market - and Tilrays share of it.
So I'll try and keep my explanation at a level you can comprehend - PM me if you need more help.
-As below, the German medical market is estimated to be $427 million USD annually.
-20% of that would equate to about $85 million USD
Here are Tilrays actual reported revenues for ALL International Medical Cannabis sales - That's in the entire world, not just Germany:
Year ending 2022. $ 52 million USD
Year ending 2023. $ 40 million USD
and on the January 9/24 financials for the first 6 months of the 2024 fiscal year
$26 million (or approx $52 million extrapolated for the full year)
AGAIN - try to understand, that's $52 million in total - for ALL international medical cannabis sales - per Tilrays own financial reports.
Let's be gracious and guess that Tilrays sales to Germany were $45 million of the $52 million - that would equate to about 10% market share of the German medical cannabis market.
Keeleretes have in the past, thanked me in PMs - please, there's no need - I'm glad to help educate you.
Post by
DaveInCalgaryon Feb 17, 2024 12:55am 
138 Views
Post# 35885554
Tilray Brands - German Cannabis Legalization Update
How big is Germany's medical cannabis market?
According to Prohibition Partners, Germany represents half of Europe's medical cannabis market, with 2023 sales of approximately €390 million ($427 million) to over 230,000 patients. Dec 29, 2023